Ownership and insider activity for IceCure Medical Ltd (ICCM): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Price
| Price | $2.06 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | IL |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-14 | Good Shad | A-Award | 131,483 | |
| 2026-08-12 | Salton David | |||
| 2026-08-14 | Tel-Tzure Tlalit Bussi | A-Award | 101,483 | |
| 2026-08-14 | Levav Shay | A-Award | 141,483 | |
| 2026-08-14 | Dotan Merav Nir | A-Award | 73,890 | |
| 2026-08-14 | Peleg Meir | A-Award | 181,483 | |
| 2026-08-12 | Chan Vincent Chun Hung | |||
| 2026-04-12 | Muchnik Naum | |||
| 2026-05-17 | Tsimerman Ronen | |||
| 2026-05-17 | Peleg Meir |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.8M | $1.5M | $4.2M | $5.8M | $3.5M | $25.6M | $23.7M | $10.5M | $7.6M | $8.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | $4.7M | 0 | 0 | $529000 | 0 | 0 |
| Receivables | $65772 | $2 | $250384 | $2 | $165000 | $771000 | $366000 | $228000 | $409000 | $331000 |
| Inventory | $319502 | $300379 | $653178 | $717338 | $1.1M | $2.0M | $2.9M | $2.3M | $2.0M | $2.6M |
| Total Current Assets | $3.2M | $1.9M | $5.2M | $6.9M | $9.6M | $30.3M | $28.1M | $14.2M | $10.8M | $12.6M |
| Property, Plant & Equipment | $61872 | $43733 | $73814 | $377440 | $613000 | $1.6M | $2.0M | $2.2M | $1.8M | $1.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | $3.3M | $1.9M | $5.3M | $7.3M | $10.2M | $32.3M | $30.2M | $16.4M | $12.6M | $13.9M |
| Accounts Payable | $124785 | $152491 | $452976 | $425667 | $645000 | $881000 | $714000 | $502000 | $1.2M | $863000 |
| Short-term Debt | 0 | $936241 | 0 | 0 | $214000 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $557115 | $1.6M | $1.2M | $3.6M | $3.7M | $4.0M | $4.3M | $3.9M | $5.5M | $4.8M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $1.2M | $2.2M | $1.9M | $4.7M | $4.6M | $5.3M | $4.8M | $4.2M | $5.7M | $4.8M |
| Retained Earnings | -$33.3M | -$39.8M | -$40.2M | -$48.5M | -$48.5M | -$58.4M | -$75.4M | -$90.1M | -$105.4M | -$120.4M |
| Total Equity | $2.1M | -$256934 | $3.4M | $2.6M | $5.6M | $27.0M | $25.4M | $12.2M | $6.9M | $9.1M |
| Total Debt | 0 | $936241 | 0 | $245177 | $332000 | $909000 | $597000 | $599000 | $459000 | $217000 |
| Net Debt | -$2.8M | -$521061 | -$4.2M | -$5.5M | -$7.8M | -$24.7M | -$23.1M | -$10.5M | -$7.1M | -$8.7M |
| Working Capital | $2.7M | $289447 | $4.0M | $3.3M | $5.9M | $26.3M | $23.8M | $10.3M | $5.2M | $7.8M |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 2.87 |
Profitability
| Return on Equity | -174.26% |
| Return on Invested Capital | -183.21% |
| Return on Assets | -95.33% |
| Gross Margin | 36.10% |
| Operating Margin | -556.35% |
| Net Margin | -427.67% |
Related companies: BDMD · CTSO · ECOR · MDAI · MDCX · PETS · SRTS
Explore sector: Healthcare · Medical - Devices
More sections of ICCM: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks